Project Number GDAPB-201807-2015702 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2019 View Full Project Details for Retinal Changes in Alzheimer’s disease (AD) Correlated with Cerebral Amyloid Staging, A Promising Early Biomarker in AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 2. Imaging Biomarkers g. Retinal Imaging Researcher and Organization Principal Investigator Shaked, Eliav Principal Investigator First Name Eliav Principal Investigator Last Name Shaked Awardee Organization RetiSpec Inc. Awardee State Ontario Contact PI Country Canada Project Detail Funding Opportunity Announcement Diagnostics Accelerator: Peripheral Biomarkers RFP FY Overall Cost $500,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
